Context Therapeutics Analyst Ratings
Context Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/07/2023 | 316.62% | HC Wainwright & Co. | → $4 | Reiterates | → Buy |
| 02/02/2022 | 524.93% | HC Wainwright & Co. | → $6 | Initiates Coverage On | → Buy |
| 01/24/2022 | 941.56% | ThinkEquity | → $10 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 02/07/2023 | 316.62% | HC Wainwright & Co. | → 4 美元 | 重申 | → 购买 |
| 2022 年 2 月 2 日 | 524.93% | HC Wainwright & Co. | → 6 美元 | 开启覆盖范围 | → 购买 |
| 2022 年 1 月 24 日 | 941.56% | ThinkEqu | → 10 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的目标价格是多少？
The latest price target for Context Therapeutics (NASDAQ: CNTX) was reported by HC Wainwright & Co. on February 7, 2023. The analyst firm set a price target for $4.00 expecting CNTX to rise to within 12 months (a possible 316.62% upside). 1 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年2月7日公布了Context Therapeutics（纳斯达克股票代码：CNTX）的最新目标股价。这家分析公司将目标价设定为4.00美元，预计CNTX将在12个月内升至316.62％（可能上涨316.62％）。1家分析公司去年公布了评级。
What is the most recent analyst rating for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的最新分析师评级是多少？
The latest analyst rating for Context Therapeutics (NASDAQ: CNTX) was provided by HC Wainwright & Co., and Context Therapeutics reiterated their buy rating.
Context Therapeutics（纳斯达克股票代码：CNTX）的最新分析师评级由HC Wainwright & Co.提供，Context Therapeutics重申了买入评级
When is the next analyst rating going to be posted or updated for Context Therapeutics (CNTX)?
Context Therapeutics（CNTX）的下一个分析师评级将在何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Context Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Context Therapeutics was filed on February 7, 2023 so you should expect the next rating to be made available sometime around February 7, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与Context Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。Context Therapeutics的最新评级是在2023年2月7日提交的，因此你应该预计下一个评级将在2024年2月7日左右公布。
Is the Analyst Rating Context Therapeutics (CNTX) correct?
分析师评级Context Therapeutics（CNTX）正确吗？
While ratings are subjective and will change, the latest Context Therapeutics (CNTX) rating was a reiterated with a price target of $0.00 to $4.00. The current price Context Therapeutics (CNTX) is trading at is $0.96, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Context Therapeutics（CNTX）评级得到了重申，目标价为0.00美元至4.00美元。Context Therapeutics（CNTX）目前的交易价格为0.96美元，在分析师的预测区间内。